Zhugang Wang

Dr. Zhugang Wang

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2007 in Cell Research
Verified
Journal Article
Open access
PDF file
YWYi Wang
Yi Wang
HZHong-Xin Zhang
Hong-Xin Zhang
YSYue-Ping Sun
Yue-Ping Sun
ZLZi-Xing Liu
Zi-Xing Liu
XLXue-Song Liu
Xue-Song Liu
ZWZhugang Wang
Zhugang Wang
RIG-I (retinoid acid-inducible gene-I), a putative RNA helicase with a cytoplasmic caspase-recruitment domain (CARD), was identified as a pattern-recognition receptor (PRR) that mediates antiviral immunity by inducing type I interferon production. To further study the biological function of RIG-I, we generated Rig-I−/− mice through homologous recombination, taking a different strategy to the previously reported strategy. Our Rig-I−/− mice are viable and fertile. Histological analysis shows that Rig-I−/− mice develop a colitis-like phenotype and increased susceptibility to dextran sulfate sodium-induced colitis. Accordingly, the size and number of Peyer's patches dramatically decreased in mutant mice. The peripheral T-cell subsets in mutant mice are characterized by an increase in effector T cells and a decrease in naïve T cells, indicating an important role for Rig-I in the regulation of T-cell activation. It was further found that Rig-I deficiency leads to the downregulation of G protein αi2 subunit (Gαi2) in various tissues, including T and B lymphocytes. By contrast, upregulation of Rig-I in NB4 cells that are treated with ATRA is accompanied by elevated Gαi2 expression. Moreover, Gαi2 promoter activity is increased in co-transfected NIH3T3 cells in a Rig-I dose-dependent manner. All these findings suggest that Rig-I has crucial roles in the regulation of Gαi2 expression and T-cell activation. The development of colitis may be, at least in part, associated with downregulation of Gαi2 and disturbed T-cell homeostasis.

3 April 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HZHong-Xin Zhang
Hong-Xin Zhang
ZLZi-Xing Liu
Zi-Xing Liu
YSYue-Ping Sun
Yue-Ping Sun
JZJiang Zhu
Jiang Zhu
SLShun-Yuan Lu
Shun-Yuan Lu
ZWZhugang Wang
Zhugang Wang
Retinoic acid inducible gene I (RIG-I) senses viral RNAs and triggers innate antiviral responses through induction of type I IFNs and inflammatory cytokines. However, whether RIG-I interacts with host cellular RNA remains undetermined. Here we report that Rig-I interacts with multiple cellular mRNAs, especially Nf-κb1 . Rig-I is required for NF-κB activity via regulating Nf-κb1 expression at posttranscriptional levels. It interacts with the multiple binding sites within 3′-UTR of Nf-κb1 mRNA. Further analyses reveal that three distinct tandem motifs enriched in the 3′-UTR fragments can be recognized by Rig-I. The 3′-UTR binding with Rig-I plays a critical role in normal translation of Nf-κb1 by recruiting the ribosomal proteins [ribosomal protein L13 (Rpl13) and Rpl8] and rRNAs (18S and 28S). Down-regulation of Rig-I or Rpl13 significantly reduces Nf-κb1 and 3′-UTR–mediated luciferase expression levels. These findings indicate that Rig-I functions as a positive regulator for NF-κB signaling and is involved in multiple biological processes in addition to host antivirus immunity.

1 July 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
XWXiao-Lin Wu
Xiao-Lin Wu
MGMing-Min Gu
Ming-Min Gu
LHLei Huang
Lei Huang
XLXue-Song Liu
Xue-Song Liu
HZHong-Xin Zhang
Hong-Xin Zhang
ZWZhugang Wang
Zhugang Wang

1 December 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
WXWang-Yang Xu
Wang-Yang Xu
MGMing-Min Gu
Ming-Min Gu
LSLian-Hua Sun
Lian-Hua Sun
Wenting GuoWenting Guo
Wenting Guo
HZHou-Bao Zhu
Hou-Bao Zhu
ZWZhugang Wang
Zhugang Wang

21 July 2018 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
XSXuan Shang
Xuan Shang
CSChunling Shen
Chunling Shen
JLJianbing Liu
Jianbing Liu
LTLingyun Tang
Lingyun Tang
HZHongxin Zhang
Hongxin Zhang
ZWZhugang Wang
Zhugang Wang
Testis-specific PRSS55 is a highly conserved chymotrypsin-like serine protease among mammalian species. So far, the physiological function of PRSS55 remains unknown. Here, we show that PRSS55 is a GPI-anchored membrane protein, specifically expressed in adult mouse testis and mainly observed in the luminal side of seminiferous tubules and sperm acrosome. Mice deficient for Prss55 develop male infertile with normal reproduction-related parameters observed. Interestingly, in vivo fertilization rate of Prss55−/− males is dramatically decreased, possibly due to incapable migration of Prss55−/− sperm from uterus into oviduct. However, in vitro fertilization rate has no difference between two genotypes although Prss55−/− sperm presents defective recognition/binding to zona-intact or zona-free oocytes. Further study reveals that mature ADAM3 is almost undetectable in Prss55−/− sperm, while precursor ADAM3 remains unchanged in the testis. However, it is shown that ADAM3 has no interaction with PRSS55 by immunoprecipitation with anti-PRSS55 antibody. The expression levels of several proteins known to be related to the observed phenotypes remain comparable between wt and Prss55−/− mice. Moreover, we found that Prss55 deficiency has no effect on PRSS37 or vice versa albeit two mutant males share almost the same phenotypes. Microarray analysis reveals a total of 72 differentially expressed genes in Prss55−/− testis, most of which are associated with cellular membrane and organelle organization, protein transport and complex assembly, and response to stimulus and signaling. In conclusion, we have demonstrated that PRSS55 plays vital roles in regulating male fertility of mice, including in vivo sperm migration and in vitro sperm–egg interaction, possibly by affecting the maturation of ADAM3 in sperm and the expression of multiple genes in testis.

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
LTLingyun Tang
Lingyun Tang
MWMin Wu
Min Wu
SLShunyuan Lu
Shunyuan Lu
HZHongxin Zhang
Hongxin Zhang
YSYan Shen
Yan Shen
ZWZhugang Wang
Zhugang Wang
Fibroblast growth factor 9 (Fgf9) is a well‐known factor that regulates bone development; however, its function in bone homeostasis is still unknown. Previously, we identified a point mutation in the FGF9 gene (p.Ser99Asn, S99N) and generated an isogeneic knock‐in mouse model, which revealed that this loss‐of‐function mutation impaired early joint formation and was responsible for human multiple synostosis syndrome 3 (SYNS3). Moreover, newborn and adult S99N mutant mice exhibited significantly increased bone mass, suggesting that Fgf9 also participated in bone homeostasis. Histomorphology, tomography and serological analysis of homozygous newborns and heterozygous adults showed that the Fgf9S99N mutation immensely increased bone mass and bone formation in perinatal and adult bones and decreased osteoclastogenesis in adult bone. An in vitro differentiation assay further revealed that the S99N mutation enhanced bone formation by promoting osteogenesis and mineralization of bone marrow mesenchymal stem cells (BMSCs) and attenuating osteoclastogenesis of bone marrow monocytes (BMMs). Considering the loss‐of‐function effect of the S99N mutation, we hypothesized that Fgf9 itself inhibits osteogenesis and promotes osteoclastogenesis. An in vitro differentiation assay revealed that Fgf9 prominently inhibited BMSC osteogenic differentiation and mineralization and showed for the first time that Fgf9 promoted osteoclastogenesis by enhancing preosteoclast aggregation and cell–cell fusion. Furthermore, specific inhibitors and in vitro differentiation assays were used and showed that Fgf9 inhibited BMSC osteogenesis mainly via the MEK/ERK pathway and partially via the PI3K/AKT pathway. Fgf9 also promoted osteoclastogenesis as a potential costimulatory factor with M‐CSF and RANKL by coactivating the MAPK and PI3K/AKT signaling pathways. Taken together, our study demonstrated that Fgf9 is a negative regulator of bone homeostasis by regulating osteogenesis and osteoclastogenesis and provides a potential therapeutic target for bone degenerative diseases.